Mycobacterium avium Subspecies Paratuberculosis and Global Health An Infectious Disease Incorporated Perspective
Gilles RG Monif*
Infectious Diseases, Incorporated - University of Florida College of Veterinary Medicine, Florida
*Corresponding Author: Gilles RG Monif, Infectious Diseases, Incorporated - University of Florida College of Veterinary Medicine, Florida.
August 16, 2023; Published: September 15, 2023
Infectious diseases have long been a primary focus of public health concern. The enhanced virulence that occurs when an organism jumps from one species to another species obligates the resultant public health threat to be aggressively addressed: antimicrobial therapy and/or vaccine development. What has received considerably less attention are zoonotic infectious disease organisms already embedded within the human biosphere. Being limited in impact, public health measures tend to be subordinated to overriding economic considerations. Rather than being proactive, these agencies tend to be more reactive in which disease becomes the opportunity that prevention missed.
The thesis of how a government agency allowed Mycobacterium avium subspecies paratuberculosis presence within nations’ food supply to be transformed into a global pandemic is derived from a 20-year collaboration between Infectious Diseases Incorporate and the University of Florida.
Keywords: Mycobacterium avium; Food and Drug Administration (FDA); United States Department of Agriculture (USDA)
- Stabel J R., et al. “Heat inactivation of Mycobacterium paratuberculosis in raw milk: are current pasteurization conditions effective?” Applied and Environmental Microbiology 63 (1997): 975-977.
- Grant I R., et al. “Effect of high-temperature short-time HTST on milk containing low level s of Mycobacterium paratuberculosis”. Letter Applied Microbiology 26 (1998): 166-170.
- Millar D Ford., et al. “IS 900 PCR to detect Mycobacterium avium subspecies paratuberculosis in retail supplies of whole pasteurized milk in England and Wales’. Applied and Environmental Microbiology 62 (1996): 3446-3454.
- McKenna SL., et al. “Evaluation of three ELISAs for Mycobacterium avium subsp. paratuberculosis using tissue and fecal culture comparison standards”. Veterinary Microbiology 110 (2005): 105-111.
- Monif G R G., et al. “The significance of a negative Map ELISA test for Mycobacterium avium subspecies paratuberculosis”. The International Journal of Applied Research in Veterinary Medicine 11 (2013): 171-122.
- Pinedo P J., et al. “Mycobacterium paratuberculosis shedding into milk: association of ELISA seroreactivity with DNA detection in milk”. The International Journal of Applied Research in Veterinary Medicine 6 (2008): 137-144.
- Hruska K and Pavlik I. “Lower incidence of Crohn’s disease in the Gipsy population of Hungary, the Maori population of New Zealand, Palestinians in Israel, Indians in Canada New Zealand”. GME 2010, Kosice, Session 6 and Veterinarni Medicina (2010).
- Hruska K., et al. “Mycobacterium avium subsp. paratuberculosis in powdered infant milk: paratuberculosis in cattle – public health problem to be solved”. Veterinarni Medicina (2005): 327-335.
- Monif G R G. “Hruska postulate”. Medical Hypothesis 85 (2015): 878-881.
- United States voluntary Johne’s disease herd status program for cattle. 2000. United States Animal Health Association (2000).
- Uniform program standards for the voluntary Johne’s disease control program. United States Department of Agriculture Animal and Plant Health Inspection Service. APIS 91-45-014.
- Cousins D V., et al. “Mycobacteria distinct from Mycobacterium avium subspecies paratuberculosis isolated from the faeces of ruminants possess IS900-like sequences detectable IS900 polymerase chain reaction: implications for diagnosis”. Molecular and Cellular Probes 13 (1999): 431-442.
- McIntyre G and Stanford J L. “Immunodiffusion analysis showed that M. paratuberculosis and other mycobactin-dependent mycobacteria are variants of M. avium”. Journal of General Microbiology 26 (1966): 21120-2123.
- Englund S., et al. “An IS900-like sequence found in a Mycobacterium sp. other than Mycobacterium avium subspecies paratuberculosis”. FEMS Microbiology Letter 209 (2002): 267-271
- USDA-APHIS Johne's Disease in U.S. Dairies 1991-2007.
- Monotami E. “Epidemiological situation and control strategies for paratuberculosis in Japan”. Japanese Journal of Veterinary Research 60 (2012): 19s-29s.
- FDA Application Number 12505710. Biological License Application 125057.
- Lichenstein GR., et al. “ACCG Clinical Guidelines: Management of Cohn’s Disease in Adults”. The American Journal of Gastroenterology 113 (2018): 481-517.
- Monif GRG. “The myth of autoimmunity”. Medical Hypothesis 121 (2018): 78-79.
- Monif G R G. “Prevention of Crohn’s disease?” Preventive Medicine 8 (2022): 1-2.
- Monif G R G. “An infectious disease process within an immune-mediated disease process: Role of the gastrointestinal microbiota in Crohn’s disease”. Advanced Research in Gastroenterology and Hepatology 5 (2017): 1-2.
- Monif GRG. “The WHYs of Crohn’s disease”. Advanced Research in Gastroenterology and Hepatology 10 (2018): 1-4.
- Monif GRG. “Are the permanent sequalae of Crohn’ s disease a failure to treat the gastrointestinal microbiota”. Medical Hypothesis 122 (2018): 198-199.
- Sigall-Boneh R., et al. “Dietary therapy with Crohn’s Disease Exclusion Diet is a successful strategy for induction of remissions in children and adults failing biological therapy”. Journal of Crohn's and Colitis 11 (2017): 1205-1212.
- Levine A., et al. “Crohn’s disease exclusion diet plus partial enteral nutrition induces sustained remission in a randomized controlled trial”. Gastroenterology 157 (2019): 440-450 e448.
- Chiba M., et al. “Life-style related disease in Crohn’s disease relapse prevention with semi-vegetarian diet”. World Journal of Gastroenterology 16 (2010): 2484-2895.